Home The Word Brain My Amedeo FAQ Privacy About


Amedeo Chinese

For Medical Students & Physicians

A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever.

Download the free PDF: Amedeo Chinese PDF

  Autoimmune Disorders

  Free Subscription


25.05.2026

1 Ann Neurol
1 BMC Neurol
2 Curr Opin Immunol
2 Diabetes
4 Intern Med
2 J Autoimmun
4 J Clin Endocrinol Metab
1 J Immunol
2 J Nephrol
1 J Neuroimmunol
5 J Neurol
1 J Pediatr Endocrinol Metab
1 J Rheumatol
2 Kidney Int
2 Mult Scler
1 Nat Rev Neurol
1 Neurology
3 PLoS One
1 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Ann Neurol

  1. DING Y, Hamitouche D, Thebault S, Kearns P, et al
    Genetic-Proteomic Integration Identifies Predictive Plasma Proteins for Multiple Sclerosis.
    Ann Neurol. 2026 May 22. doi: 10.1002/ana.78256.
    PubMed         Abstract available


    BMC Neurol

  2. AHMED GU, Abbas H, Komal F, Muskan F, et al
    Efficacy of transcranial direct current stimulation on motor and cognitive functions in patients with multiple sclerosis: a systematic review and meta-analysis.
    BMC Neurol. 2026 May 15. doi: 10.1186/s12883-026-04961.
    PubMed         Abstract available


    Curr Opin Immunol

  3. PERICLEOUS C, Strauss E, Arachchillage DJ
    Endothelial dysfunction in APS: advancing pathophysiological understanding to improve management.
    Curr Opin Immunol. 2026;100:102745.
    PubMed         Abstract available

  4. TONUTTI A, D'Amico S, Timilsina S, Gershwin ME, et al
    Use of synthetic data, a novel paradigm for immunopathology.
    Curr Opin Immunol. 2026;100:102753.
    PubMed         Abstract available


    Diabetes

  5. YE J, Qiu Y, Aguilan JT, Sun Y, et al
    The Downregulation of Type 1 Diabetes Susceptibility Gene PGM1 Induces Metabolic Imbalance and Stress in Pancreatic beta-Cells.
    Diabetes. 2026 Mar 31:db250191. doi: 10.2337/db25-0191.
    PubMed         Abstract available

  6. MONTASER E, Sosenko JM, Ismail HM
    Predicting the Timing of the Metabolic Inflection Point in Type 1 Diabetes Progression Using Machine Learning and Survival Analysis Models.
    Diabetes. 2026 Mar 20:db250961. doi: 10.2337/db25-0961.
    PubMed         Abstract available


    Intern Med

  7. YAMAMOTO U, Oba Y, Rikihisa T, Taniguchi S, et al
    Eosinophilic Granulomatosis with Polyangiitis that Manifested after Administration of Benralizumab in a Patient with Refractory Recurrent Bronchial Asthma.
    Intern Med. 2026;65:1372-1376.
    PubMed         Abstract available

  8. SUZUKI S, Otani T, Nishi T, Ikeda K, et al
    Two-year Outcomes of Remission Induction Therapy with Mepolizumab for Eosinophilic Granulomatosis with Polyangiitis: A Case Series.
    Intern Med. 2026;65:1416-1420.
    PubMed         Abstract available

  9. MATSUMOTO T, Shima C, Suga H, Kajiwara Y, et al
    Central Retinal Artery Occlusion Induced by Dupilumab: A Unique Manifestation of Eosinophilic Granulomatosis with Polyangiitis.
    Intern Med. 2026;65:1392-1396.
    PubMed         Abstract available

  10. IKEDA A, Konishi T, Maruta M, Kutsuna T, et al
    Ampicillin-dependent IgG Antibody Mediated Thrombocytopenia Confirmed Using Flow Cytometry.
    Intern Med. 2026;65:1397-1401.
    PubMed         Abstract available


    J Autoimmun

  11. SORGJERD EP, Hals IK, Lonnum BE, Edstorp J, et al
    Impacts of HLA-DR3DQ2 and HLA-DR4DQ8 haplotypes singly and combined on autoimmunity, phenotype and comorbidity in patients with Latent Autoimmune Diabetes in the adult. Results from the HUNT and ESTRID studies.
    J Autoimmun. 2026;161:103576.
    PubMed         Abstract available

  12. OREFICE NS, Meijns NRC, Di Martino E, Schepers M, et al
    PAD2-mediated citrullination of MBP and early myelin destabilization in multiple sclerosis.
    J Autoimmun. 2026;161:103577.
    PubMed         Abstract available


    J Clin Endocrinol Metab

  13. TANABE H, Shimajiri Y, Shiroma K, Higa M, et al
    Unequal distribution of plasma glucagon levels among clustering-based diabetes subtypes: a Japanese cohort.
    J Clin Endocrinol Metab. 2025 Dec 13:dgaf654. doi: 10.1210.
    PubMed         Abstract available

  14. DIXIT SB, Marcelli M, Tong C, Chen Z, et al
    US Patterns in Clinical Islet Autoantibody Ordering and Results Show Key Differences After Teplizumab Regulatory Approval.
    J Clin Endocrinol Metab. 2026 May 15:dgag200. doi: 10.1210.
    PubMed         Abstract available

  15. STERGIANOS S, Everhov AH, Soderling J, Skov J, et al
    Work Loss and Income Before and After Diagnosis of Addison's Disease: A Population-Based Longitudinal Study.
    J Clin Endocrinol Metab. 2026;111:e1562-e1572.
    PubMed         Abstract available

  16. CHEN J, Wu Y, Li F, Guo Q, et al
    Causal effect of type 1 diabetes on juvenile idiopathic arthritis and the mediating role of CD8+ natural killer T cells.
    J Clin Endocrinol Metab. 2025 Dec 15:dgaf664. doi: 10.1210.
    PubMed         Abstract available


    J Immunol

  17. PATINO-MARTINEZ E, Hajihosseini M, Hanata N, Jiang K, et al
    Longitudinal multiomic and spatial transcriptomic profiling of lupus nephritis progression in a murine model.
    J Immunol. 2026;215:vkag100.
    PubMed         Abstract available


    J Nephrol

  18. NGUYEN MK, Chou A, Ramachandran R, Kurien AA, et al
    Complementary and alternative medicine-associated membranous nephropathy: a systematic review.
    J Nephrol. 2026 May 18:aajaf036. doi: 10.1093.
    PubMed         Abstract available

  19. MA XJ, Liu JX, Yang WG, Sun A, et al
    Telitacicept for refractory IgA nephropathy: a case series.
    J Nephrol. 2026 May 20:aajag012. doi: 10.1093.
    PubMed         Abstract available


    J Neuroimmunol

  20. LI V, Pandey K, Binder MD, Reid HH, et al
    Identification of an immunogenic epitope from RASGRP2 with specificity for HLA-DR15 in multiple sclerosis.
    J Neuroimmunol. 2026;418:578971.
    PubMed         Abstract available


    J Neurol

  21. GUO J, Johansson E, Hillert J, Olsson T, et al
    Trajectories of processing speed in multiple sclerosis across disease-modifying therapies.
    J Neurol. 2026;273:324.
    PubMed         Abstract available

  22. PAN J, Yaguchi H, Kudo A, Fujii S, et al
    Nationwide screening identifies an expanded clinical spectrum of anti-KLHL11 antibody-associated neurologic disease in Japan.
    J Neurol. 2026;273:321.
    PubMed         Abstract available

  23. BERGAMASCHI R, Ferraro OE, Pisoni E, Fronza M, et al
    Correction: Ozone pollution as a possible trigger for multiple sclerosis in young people: the PEDIGREE study.
    J Neurol. 2026;273:319.
    PubMed        

  24. ROMANO F, Valsasina P, Albergoni M, Amato MP, et al
    Increased functional network connectivity following cognitive rehabilitation in progressive multiple sclerosis with moderate to severe disabilty: findings from the CogEx study.
    J Neurol. 2026;273:325.
    PubMed         Abstract available

  25. SURCINELLI A, Panzera I, Piscaglia MG, Zagnoli S, et al
    Late-onset multiple sclerosis is associated with relapse-independent disability accrual: a propensity score-weighted recurrent-event study.
    J Neurol. 2026;273:332.
    PubMed         Abstract available


    J Pediatr Endocrinol Metab

  26. TEPE D, Deligozoglu D, Baskan C, Goren R, et al
    Clinical course of Graves' orbitopathy in children with newly diagnosed hyperthyroidism: a prospective observational study.
    J Pediatr Endocrinol Metab. 2026 May 20. doi: 10.1515/jpem-2026-0095.
    PubMed         Abstract available


    J Rheumatol

  27. CLIFFORD AH, Thai J, Yip A, Homik J, et al
    How Often Does Follow up 18F-FDG PET Improve in Treated Patients with Giant Cell Arteritis: a Systematic Review and Meta-Analysis.
    J Rheumatol. 2026 May 15:jrheum.2026-0050. doi: 10.3899/jrheum.2026-0050.
    PubMed         Abstract available


    Kidney Int

  28. KURZHAGEN JT, Laqua W, Schiffer M, Grieshaber-Bouyer R, et al
    T-cell engagers mediate deep cell depletion beyond autoimmunity.
    Kidney Int. 2026;109:1081-1084.
    PubMed         Abstract available

  29. SEIKRIT C, Floege J
    Beyond galactose-deficient IgA1: reconsidering IgA2 as a pathogenic driver in IgA nephropathy.
    Kidney Int. 2026;109:1091-1094.
    PubMed         Abstract available


    Mult Scler

  30. POISSON KE, Anjum R, Gyang T, Eisner M, et al
    Impact of adverse childhood experiences on long-term quality of life in adults with pediatric-onset multiple sclerosis.
    Mult Scler. 2026 May 20:13524585261444237. doi: 10.1177/13524585261444237.
    PubMed         Abstract available

  31. NAZZI C, Turrini S, Pezzetta R, Scarpazza C, et al
    Transcranial magnetic stimulation in multiple sclerosis: Targeting symptoms through neuroplasticity.
    Mult Scler. 2026 May 19:13524585261442777. doi: 10.1177/13524585261442777.
    PubMed         Abstract available


    Nat Rev Neurol

  32. PROSPERINI L, Tortorella C, Barkhof F, Battistini L, et al
    Rethinking prognosis in multiple sclerosis: a multiaxial perspective.
    Nat Rev Neurol. 2026 May 19. doi: 10.1038/s41582-026-01212.
    PubMed         Abstract available


    Neurology

  33. VAN STEENHOVEN RW, Bastiaansen AEM, Kerstens J, Crijnen YS, et al
    Autoimmune Encephalitis as Treatment-Responsive Cause of Rapidly Progressive Dementia: A Multicenter Prospective Cohort Study.
    Neurology. 2026;106:e214933.
    PubMed         Abstract available


    PLoS One

  34. ALWABRAN AI, Aldoseri GM, Aldoseri GM, Mohager SO, et al
    Decoding the genetic basis of demyelination: Prediction of potential pathogenic coding and regulatory noncoding MBP SNPs in multiple sclerosis.
    PLoS One. 2026;21:e0347598.
    PubMed         Abstract available

  35. DENG Y, Tang Z, Chen Q, Hu X, et al
    Computational biology exposed a common pathogenic mechanism in influenza A and Guillain-Barre syndrome.
    PLoS One. 2026;21:e0349687.
    PubMed         Abstract available

  36. LAI KKH, Aljufairi FMAA, Sebastian JU, Liao X, et al
    Cornea biomechanics and biometric evaluations in immunoglobulin G4-related ophthalmic disease.
    PLoS One. 2026;21:e0347998.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  37. MONNI L, Kornau HC, Podesta A, Sammons RP, et al
    The functional impact of LGI1 autoantibodies on human CA3 pyramidal neurons.
    Proc Natl Acad Sci U S A. 2026;123:e2510121123.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Autoimmune Disorders is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum